Literature DB >> 2125976

Immune activation markers to predict AIDS and survival in HIV-1 seropositives.

D Fuchs1, H Jäger, M Popescu, G Reibnegger, E R Werner, M P Dierich, W Kaboth, G P Tilz, H Wachter.   

Abstract

Neopterin concentrations in body fluids of HIV-1 seropositives provide predictive information. In 1986, we examined serum and urine neopterin concentrations in 29 HIV-1 seropositives. Serum levels of soluble IL-2 receptor (sIL2R), soluble CD8 (sCD8), tumour necrosis factor alpha (TNF-alpha) and circulating immune complexes (CIC) were retrospectively analysed in 1989. All individuals had increased serum and urine neopterin, sIL2R and CIC concentrations, 27/29 had increased sCD8 concentrations, whereas all had normal TNF-alpha levels. During a 3-year follow-up, high urine and serum neopterin concentrations were significantly associated with progression to AIDS and with the occurrence of AIDS-associated death. Both neopterin variables were of similar predictive value (p less than 0.001, generalized Wilcoxon test). sIL2R concentrations were of borderline significance in predicting the onset of AIDS (p = 0.05). All other parameters lacked predictive information in our study. We conclude, that chronic immune activation is detectable in almost all HIV-1 seropositives. Chronic immune activation may be associated with HIV-1 replication and may contribute to the immunopathology of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125976     DOI: 10.1016/0165-2478(90)90178-s

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

Review 1.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 2.  Neopterin as a biomarker of immune response in cancer patients.

Authors:  Bohuslav Melichar; Martina Spisarová; Marie Bartoušková; Lenka Kujovská Krčmová; Lenka Javorská; Hana Študentová
Journal:  Ann Transl Med       Date:  2017-07

Review 3.  Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.

Authors:  D Fuchs; A Krämer; G Reibnegger; E R Werner; M P Dierich; J J Goedert; H Wachter
Journal:  Infection       Date:  1991       Impact factor: 3.553

4.  Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Authors:  N Aziz; P Nishanian; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

5.  Variables that affect assays for plasma cytokines and soluble activation markers.

Authors:  N Aziz; P Nishanian; R Mitsuyasu; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

6.  Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.

Authors:  Timothy Lahey; Mimi Ghosh; John V Fahey; Zheng Shen; Lucy R Mukura; Yan Song; Susan Cu-Uvin; Kenneth H Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

7.  Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.

Authors:  Giuseppe Corano Scheri; Saeid Najafi Fard; Ivan Schietroma; Andrea Mastrangelo; Claudia Pinacchio; Noemi Giustini; Sara Serafino; Gabriella De Girolamo; Eugenio Nelson Cavallari; Maura Statzu; Luca Laghi; Annamaria Vullo; Giancarlo Ceccarelli; Vincenzo Vullo; Gabriella d'Ettorre
Journal:  Int J Tryptophan Res       Date:  2017-05-30

Review 8.  Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.

Authors:  Johanna M Gostner; Kathrin Becker; Katharina Kurz; Dietmar Fuchs
Journal:  Front Psychiatry       Date:  2015-07-14       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.